Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

M F Muldoon 1, S B Manuck 1, K A Matthews 1
PMCID: PMC1663605  PMID: 2144195

Abstract

OBJECTIVE--To determine the effects of lowering cholesterol concentrations on total and cause specific mortality in randomised primary prevention trials. DESIGN--Qualitative (meta-analytic) evaluation of total mortality from coronary heart disease, cancer, and causes not related to illness in six primary prevention trials of cholesterol reduction (mean duration of treatment 4.8 years). PATIENTS--24,847 Male participants; mean age 47.5 years. MAIN OUTCOME MEASURES--Total and cause specific mortalities. RESULTS--Follow up periods totalled 119,000 person years, during which 1147 deaths occurred. Mortality from coronary heart disease tended to be lower in men receiving interventions to reduce cholesterol concentrations compared with mortality in control subjects (p = 0.06), although total mortality was not affected by treatment. No consistent relation was found between reduction of cholesterol concentrations and mortality from cancer, but there was a significant increase in deaths not related to illness (deaths from accidents, suicide, or violence) in groups receiving treatment to lower cholesterol concentrations relative to controls (p = 0.004). When drug trials were analysed separately the treatment was found to reduce mortality from coronary heart disease significantly (p = 0.04). CONCLUSIONS--The association between reduction of cholesterol concentrations and deaths not related to illness warrants further investigation. Additionally, the failure of cholesterol lowering to affect overall survival justifies a more cautious appraisal of the probable benefits of reducing cholesterol concentrations in the general population.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canner P. L., Berge K. G., Wenger N. K., Stamler J., Friedman L., Prineas R. J., Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986 Dec;8(6):1245–1255. doi: 10.1016/s0735-1097(86)80293-5. [DOI] [PubMed] [Google Scholar]
  2. Coccaro E. F. Central serotonin and impulsive aggression. Br J Psychiatry Suppl. 1989 Dec;(8):52–62. [PubMed] [Google Scholar]
  3. Coscina D. V., Yehuda S., Dixon L. M., Kish S. J., Leprohon-Greenwood C. E. Learning is improved by a soybean oil diet in rats. Life Sci. 1986 May 12;38(19):1789–1794. doi: 10.1016/0024-3205(86)90130-x. [DOI] [PubMed] [Google Scholar]
  4. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  5. Dorr A. E., Gundersen K., Schneider J. C., Jr, Spencer T. W., Martin W. B. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978 Jan;31(1):5–14. doi: 10.1016/0021-9681(78)90076-0. [DOI] [PubMed] [Google Scholar]
  6. Frantz I. D., Jr, Dawson E. A., Ashman P. L., Gatewood L. C., Bartsch G. E., Kuba K., Brewer E. R. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis. 1989 Jan-Feb;9(1):129–135. doi: 10.1161/01.atv.9.1.129. [DOI] [PubMed] [Google Scholar]
  7. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  8. Holinger P. C., Klemen E. H. Violent deaths in the United States, 1900-1975. Relationships between suicide, homicide and accidental deaths. Soc Sci Med. 1982;16(22):1929–1938. doi: 10.1016/0277-9536(82)90392-6. [DOI] [PubMed] [Google Scholar]
  9. Isles C. G., Hole D. J., Gillis C. R., Hawthorne V. M., Lever A. F. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ. 1989 Apr 8;298(6678):920–924. doi: 10.1136/bmj.298.6678.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jenkins C. D., Hames C. G., Zyzanski S. J., Rosenman R. H., Friedman M. Psychological traits and serum lipids. I. Findings from the California Psychological Inventory. Psychosom Med. 1969 Mar-Apr;31(2):115–128. doi: 10.1097/00006842-196903000-00004. [DOI] [PubMed] [Google Scholar]
  11. Kessler A. R., Kessler B., Yehuda S. Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and a plant oil mixture. Biochem Pharmacol. 1985 Apr 1;34(7):1120–1121. doi: 10.1016/0006-2952(85)90620-3. [DOI] [PubMed] [Google Scholar]
  12. Kessler A. R., Kessler B., Yehuda S. In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indications for interactions between hippocampal-cortical cholesterol and learning. Life Sci. 1986 Mar 31;38(13):1185–1192. doi: 10.1016/0024-3205(86)90173-6. [DOI] [PubMed] [Google Scholar]
  13. Kivelä S. L. Relationship between suicide, homicide and accidental deaths among the aged in Finland in 1951-1979. Acta Psychiatr Scand. 1985 Aug;72(2):155–160. doi: 10.1111/j.1600-0447.1985.tb02588.x. [DOI] [PubMed] [Google Scholar]
  14. Kolata G. Heart panel's conclusions questioned. Science. 1985 Jan 4;227(4682):40–41. doi: 10.1126/science.3880617. [DOI] [PubMed] [Google Scholar]
  15. Krasno L. R., Kidera G. J. Clofibrate in coronary heart disease. Effect on morbidity and mortality. JAMA. 1972 Feb 14;219(7):845–851. [PubMed] [Google Scholar]
  16. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  17. McCormick J., Skrabanek P. Coronary heart disease is not preventable by population interventions. Lancet. 1988 Oct 8;2(8615):839–841. doi: 10.1016/s0140-6736(88)92795-x. [DOI] [PubMed] [Google Scholar]
  18. McMichael A. J., Jensen O. M., Parkin D. M., Zaridze D. G. Dietary and endogenous cholesterol and human cancer. Epidemiol Rev. 1984;6:192–216. doi: 10.1093/oxfordjournals.epirev.a036271. [DOI] [PubMed] [Google Scholar]
  19. Oliver M. F. Reducing cholesterol does not reduce mortality. J Am Coll Cardiol. 1988 Sep;12(3):814–817. doi: 10.1016/0735-1097(88)90327-0. [DOI] [PubMed] [Google Scholar]
  20. Pearce M. L., Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet. 1971 Mar 6;1(7697):464–467. doi: 10.1016/s0140-6736(71)91086-5. [DOI] [PubMed] [Google Scholar]
  21. Pekkanen J., Nissinen A., Punsar S., Karvonen M. J. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. The Finnish cohorts of the Seven Countries Study. Arch Intern Med. 1989 Jul;149(7):1589–1591. [PubMed] [Google Scholar]
  22. Rinzler S. H. Primary prevention of coronary heart disease by diet. Bull N Y Acad Med. 1968 Aug;44(8):936–949. [PMC free article] [PubMed] [Google Scholar]
  23. Roy A., Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand. 1988 Nov;78(5):529–535. doi: 10.1111/j.1600-0447.1988.tb06380.x. [DOI] [PubMed] [Google Scholar]
  24. Taylor W. C., Pass T. M., Shepard D. S., Komaroff A. L. Cholesterol reduction and life expectancy. A model incorporating multiple risk factors. Ann Intern Med. 1987 Apr;106(4):605–614. doi: 10.7326/0003-4819-106-4-605. [DOI] [PubMed] [Google Scholar]
  25. Turpeinen O., Karvonen M. J., Pekkarinen M., Miettinen M., Elosuo R., Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979 Jun;8(2):99–118. doi: 10.1093/ije/8.2.99. [DOI] [PubMed] [Google Scholar]
  26. Virkkunen M., De Jong J., Bartko J., Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch Gen Psychiatry. 1989 Jul;46(7):604–606. doi: 10.1001/archpsyc.1989.01810070030004. [DOI] [PubMed] [Google Scholar]
  27. Virkkunen M., Penttinen H. Serum cholesterol in aggressive conduct disorder: a preliminary study. Biol Psychiatry. 1984 Mar;19(3):435–439. [PubMed] [Google Scholar]
  28. Virkkunen M. Serum cholesterol in antisocial personality. Neuropsychobiology. 1979;5(1):27–30. doi: 10.1159/000117660. [DOI] [PubMed] [Google Scholar]
  29. Virkkunen M. Serum cholesterol levels in homicidal offenders. A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology. 1983;10(2-3):65–69. doi: 10.1159/000117987. [DOI] [PubMed] [Google Scholar]
  30. Yehuda S., Leprohon-Greenwood C. E., Dixon L. M., Coscina D. V. Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol Biochem Behav. 1986 Jun;24(6):1775–1777. doi: 10.1016/0091-3057(86)90519-8. [DOI] [PubMed] [Google Scholar]
  31. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES